Instrument Inactif

Communiqués GeneNews Ltd Toronto S.E.

Actions

CA36870T2065

Recherche biotechnologique et médicale

Communiqués

21/01	StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing	AQ
14/08/25	StageZero Announces Listing on the NEX Exchange	AQ
25/07/25	StageZero Announces Delisting from the TSX and a Concomitant Application for Listing on the NEX Exchange	AQ
13/05/25	StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer	AQ
07/05/25	StageZero Announces Partial Revocation of Cease Trade Order and Proposed Financing	AQ
16/12/24	GeneNews: Q3 Earnings Snapshot	AQ
16/12/24	StageZero Life Sciences, Ltd Announces Q3 2024 Financial Results and Operational Update	AQ
01/10/24	StageZero Life Sciences, Ltd Announces Q2 2024 Financial Results and Operational Update	AQ
30/09/24	GeneNews: Q2 Earnings Snapshot	AQ
16/05/24	GeneNews: Q1 Earnings Snapshot	AQ
09/04/24	Canadian Investment Regulatory Organization Trading Halt - SZLS	AQ
08/04/24	StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order	AQ
04/12/23	Canadian Investment Regulatory Organization Trading Halt - SZLS.WS	AQ
16/11/23	StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update	AQ
15/11/23	GeneNews: Q3 Earnings Snapshot	AQ
23/10/23	StageZero Life Sciences Clinical Business Introduces Third Pillar to Cancer Offerings	AQ
15/08/23	GeneNews: Q2 Earnings Snapshot	AQ
29/06/23	Canadian Investment Regulatory Organization Trading Halt - SZLS.WT	AQ
16/05/23	StageZero to Issue Q1 2023 Financial Results after Market Closes May 15, 2023	AQ
16/05/23	GeneNews: Q1 Earnings Snapshot	AQ
16/11/22	StageZero Life Sciences, Ltd Announces Q3 2022 Financial Results and Operational Update	AQ
15/11/22	GeneNews: Q3 Earnings Snapshot	AQ
18/08/22	StageZero Life Sciences : Announces Solutions for Employers to Help Improve Cancer Outcomes	PU
16/08/22	GeneNews: Q2 Earnings Snapshot	AQ
16/08/22	StageZero Life Sciences : Announces Q2 2022 Financial Results and Operational Update	PU